Childhood Hepatitis B

China is a country with a high incidence of hepatitis B, and mother-to-child transmission is an important route for children in China to contract the hepatitis B virus (HBV). Although chronic HBV infection in childhood rarely progresses to active hepatitis, there is still a risk of developing cirrhosis and liver cancer. Therefore, understanding the epidemiological characteristics of childhood hepatitis B and taking effective prevention and control measures are particularly important to reduce the incidence of childhood hepatitis B in China and promote healthy growth. In recent years, as the goal of clinical cure for hepatitis B has gradually gained more attention, the issue of clinical cure for childhood hepatitis B has also received increasing focus. At the recently concluded "15th Academic Conference on Antiviral Therapy Difficulties and Hotspots in Chronic Viral Hepatitis," Dr. Fusheng Wang from the Fifth Medical Center of the PLA General Hospital presented a special report on "Treatment and Clinical Cure of Childhood Hepatitis B," offering an in-depth analysis of these issues.